Recall events
/
Event 88873
Event summary
Timeline bucket October 25, 2021
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording SUN PHARMACEUTICAL INDUSTRIES INC
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
2 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 2
Tadalafil Tablets, USP 5 mg, 30 count bottle, Rx Only, Manufactured for: Northstar Rx LLC Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Industries Limited, India, NDC # 16714-075-01
D-0230-2022
Recall number D-0230-2022
Initiated October 25, 2021
Classification Class II
Status Terminated
Quantity 73,957 30-count bottles
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.
Code information Lot # DNC1127A, exp. date 05/2023
Distribution pattern Distributed to one distributor who may have further distribute the product nationwide.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12990]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 2
Tadalafil Tablets, USP 20 mg, 30 count bottle, Rx Only, Manufactured for: Northstar Rx LLC Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Industries Limited, India, NDC # 16714-077-01
D-0231-2022
Recall number D-0231-2022
Initiated October 25, 2021
Classification Class II
Status Terminated
Quantity 36,786 30-count bottles
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.
Code information Lot # DNC0814A, DNC0815A, Exp. Date 04/2023
Distribution pattern Distributed to one distributor who may have further distribute the product nationwide.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12321]
FDA event record
· Exact recall-number query on openFDA
